Harvard-Vision Clinical Scientist Development Program (K12)
Summary. The Harvard Department of Ophthalmology is one of the leading and largest academic departments of Ophthalmology in the nation and a major recipient of NIH funding. With nearly 150 full-time clinical and basic science faculty, it continues to make significant contributions to ophthalmic and vision research in virtually all basic, applied, and clinical subspecialty areas. The Harvard-Vision Clinical Scientist Development Program proposes to offer a customized and structured learning, research, and development environment to a select group of qualified clinically-trained candidates who have recently completed (or about to complete) their training, but who desire further mentored learning experience so as to become independent leading clinical scientists in their respective fields. Trainees in this program will (i) complete a core curriculum that will include the Harvard Program in Clinical Effectiveness (PCE) – a summer-long immersion program in biostatistics, epidemiology, study design, and outcomes measurement. Additional required curricular activities will include the Harvard Medical School course, HBTM 303qc “Introduction to the Visual System”, a multidisciplinary survey course focusing on the biological mechanisms (genetics, immunology, neuroscience, vascular biology) of eye disease. Candidates will also (ii) perform research in a closely mentored program under the guidance of lead mentors who are leaders in their respective fields with the express objective of allowing them to develop into independent investigators. Trainees in this program will additionally have the option of seeking an advanced degree (MS, MPH, PhD, ScD) at Harvard.
Background. The extraordinary growth and specialization that has occurred over the past several decades in the sciences has made it increasingly difficult to link the increasing divide between clinical and basic science components of ophthalmic and vision sciences. The less-than-optimal degree of cross-talk between scientists engaged in studying fundamental biological processes and clinicians providing care to patients has had multiple deleterious effects. Continued external factors are expected to impact this trend negatively for the foreseeable future. Traditional approaches, based purely on didactic curricula, to “teach” basic sciences to highly-trained clinicians are only variably effective as they offer limited opportunity to these clinicians for hands-on experience in designing and conducting studies. Additionally, many clinicians engaged in pure clinical (vs. bench-based) research have had very limited formal training in methodological aspects of clinical study design and execution.
To address these needs the Harvard-Vision Clinical Scientist Development Program is seeking to recruit and train clinician-scientists as detailed below.
We are seeking subspecialty/fellowship-trained board-certified/eligible ophthalmologists (or optometrists) to commit, at the level of Junior Faculty with 75% of their time dedicated to structured research (up to 25% clinical work) and the development program under mentorship of one of our senior faculty. The duration of commitment will be 3-5 years based on the interests of the candidate and the nature of the mentored training program.
A position is available throughout the Harvard Ophthalmology system for July 1 of the next academic year.
Interested applicants should contact Cori O’Brien at 617-573-3311 or cori_o’brien@meei.harvard.edu for an application. Applicants should also identify a mentor within the Harvard faculty or MIT community and contact them to discuss potential mentor relationship if accepted into the program.
In addition please submit (1) a complete curriculum vitae, (2) 1-2 page letter of intent describing how this mechanism will further your career in vision science, (4) 1-2 page Scientific Proposal (4) 3 letters of recommendation to Reza Dana, MD, MPH c/o Cori O’Brien Massachusetts Eye & Ear Infirmary 243 Charles St, Boston, MA 02114. US citizenship or resident alien status (green card) is required for acceptance to the program.
Application deadline is December 15 for the following July 1.
This program is funded by the National Institutes of Health. We are an Equal Opportunity/Affirmative Action Employer. Women & Minorities are encouraged to apply.
Scope of Research and List of Mentors
Below, are tables listing the ophthalmic subspecialty areas, and academic disciplines and related faculty, offered through the Harvard-Vision Clinical Scientist Development Program.
|
BWH |
Brigham & Women’s Hospital |
|
Children’s |
Boston Children’s Hospital |
|
HMS |
Harvard Medical School |
|
HSPH |
Harvard School of Public Health |
|
HU |
Harvard University |
|
JDC |
Joslin Diabetes Center |
|
MEEI |
Massachusetts Eye & Ear Infirmary |
|
MGH |
Massachusetts General Hospital |
|
SERI |
Schepens Eye Research Institute |
|
Ocular Area of Concentration
|
Mentors & Faculty
(may be listed in >1 area of expertise)
|
Institution
|
|
Cornea & Anterior Segment
|
Pablo Argüeso, PhD
Reza Dana, MD, MSc, MPH
Darlene Dartt, PhD
Ilene Gipson, PhD
Ula Jurkunas, MD
James Zieske, PhD
|
SERI
MEEI & SERI
SERI
SERI
SERI
SERI
|
|
Glaucoma
|
Louis Pasquale, MD
Janey L. Wiggs, MD, PhD
|
MEEI
MEEI
|
|
Inherited Retinopathies
|
Eliot Berson, MD
Eric Pierce, MD, PhD
|
MEEI
MEEI
|
|
Low Vision
|
Alex Bowers, PhD
Eli Peli, OD
David G. Hunter, MD (pediatric)
|
SERI
SERI
Children’s
|
|
Macular Degeneration
|
Dean Eliott, MD
Evangelos Gragoudas, MD
Joan Miller, MD
|
MEEI
MEEI
MEEI
|
|
Nutrition & Disease
|
Susan Hankinson, ScD, MPH
Debra Schaumberg, ScD, MPH
|
HMS
BWH
|
|
Ocular Inflammation & Microbiology
|
James Chodosh, MD
Reza Dana, MD, MSc, MPH
Michael Gilmore, PhD
|
MEEI
MEEI & SERI
MEEI
|
|
Ocular Oncology
|
Evangelos Gragoudas, MD
|
MEEI
|
|
Pediatric Ophthalmology
|
David G. Hunter, MD
|
Children’s
|
|
Proliferative Vitreoretinopathy
|
Lloyd Paul Aiello, MD, PhD
Robert D’Amato, MD, PhD
Patricia D’Amore, PhD
Andrius Kazlauskas, PhD
Mara Lorenzi, MD
Joan Miller, MD
Lois Smith, MD, PhD
|
JDC
Children’s & MEEI
SERI
SERI
SERI & MGH
MEEI
Children’s
|
|
Retinal Physiology & Development
|
Larry Benowitz, PhD
Connie Cepko, PhD
John Dowling, PhD
Richard Masland, PhD
|
Children’s
HMS
HU, Biological Labs
MEEI
|
|
Tear Film & Ocular Surface
|
Reza Dana, MD, MSc, MPH
Darlene Dartt, PhD
Ilene Gipson, PhD
David Sullivan, PhD
James Zieske, PhD
|
SERI
SERI
SERI
SERI
SERI
|
|
Academic Discipline
|
Mentors & Faculty
(may be listed in >1 area of expertise)
|
Institution
|
|
Biostatistics & Epidemiology
|
Robert Glynn, ScD
Susan Hankinson, ScD, MPH
Louis Pasquale, MD
Debra Schaumberg, ScD, MPH
Meir Stampfer, MD, DrPH
|
BWH
HMS
MEEI
BWH
HSPH
|
|
Cell Biology
|
Ilene Gipson, PhD
Ula Jurkunas, MD
Andrius Kazlauskas, PhD
James Zieske, PhD
|
SERI
SERI
SERI
SERI
|
|
Clinical Trials
|
Francis Cook, ScD, MS
Dean Eliott, MD
Robert Glynn, ScD
Evangelos Gragoudas, MD
Joan Miller, MD
Louis Pasquale, MD
Debra Schaumberg, MSc, MPH
|
HMS, Clin. Effect. Prog.
MEEI
BWH
MEEI
MEEI
MEEI
BWH
|
|
Development
|
John Dowling, PhD
|
HMS, Biological Labs
|
|
Genetics
|
Eliot Berson, MD
Connie Cepko
Eric Pierce, MD, PhD
Janey Wiggs, MD, PhD
|
MEEI
HMS
MEEI
MEEI
|
|
Immunology & Microbiology
|
Pablo Argüeso, PhD
James Chodosh, MD
Reza Dana, MD, MSc, MPH
Michael Gilmore, PhD
|
SERI
MEEI
MEEI & SERI
MEEI
|
|
Matrix Remodeling & Angiogenesis
|
Lloyd Paul Aiello, MD, PhD
Patricia D’Amore, PhD
Reza Dana, MD, MSc, MPH
Joan Miller, MD
|
JDC
SERI
MEEI & SERI
MEEI
|
|
Neurobiology
|
Larry Benowitz, PhD
John Dowling, PhD
Richard Masland, PhD
|
Children’s
HMS, Biological Labs
MEEI
|
|
Optics
|
Alex Bowers, PhD
Eli Peli, OD
|
SERI
SERI
|
|
Physiology
|
Darlene Dartt, PhD
Ilene Gipson, PhD
David Hunter, MD, PhD
David Sullivan, PhD
James Zieske, PhD
|
SERI
SERI
Children’s
SERI
SERI
|
|
Vascular & Endothelial Biology
|
Lloyd Paul Aiello, MD, PhD
Patricia D’Amore, PhD
Mara Lorenzi, MD
Lois Smith, MD, PhD
|
JDC
SERI
SERI & MGH
Children’s
|



